Beyond 5 ‐year survival. A report from the Cooperative Osteosarcoma Study Group (COSS)

ConclusionThis benchmark analysis clearly defined risk factors for the further course of 5-year survivors from osteosarcoma. It argues for large disease-oriented databases as well as for very long follow-up periods. Novel findings will most likely require innovative statistical models to analyze such cohorts.

Source: Cancer Medicine - January 29, 2024 Category: Cancer & Oncology Authors: Julia S. Fernandes, Claudia Blattmann, Stefanie Hecker ‐Nolting, Leo Kager, Matthias Kevric, Vanessa Mettmann, Benjamin Sorg, Marc Fernandes, Stefan S. Bielack Tags: RESEARCH ARTICLE Source Type: research